David Whitehouse's Email Addresses & Phone Numbers

Independent Consultant @ David Whitehouse MD Working with clients including InVentiv Medical Management to create the new era of integrated Medical Management applications that include CM/DM/UM; including the development of clinical decision support tools integrated into the PHR/HER. Other foci include improved data capture to better leverage a Total Cost of Care perspective; the new focus on...

Independent Consultant @ David Whitehouse MD Working with clients including InVentiv Medical Management to create the new era of integrated Medical Management applications that include CM/DM/UM; including the development of clinical decision support tools integrated into the PHR/HER. Other foci include improved data capture to better leverage a Total Cost of Care perspective; the new focus on big data, crowd sourcing and patient registries to help drive CER; a focus on revenue maximization with MU and STAR; an understanding of the ethical cliff posed by the expense of new technology solutions and medications and the incorporation of technology into consumer engagement, in home monitoring and greater focus on the “expert patient”; and using the latest advances in behavioral neuroscience and behavioral economics to maximize patient engagement, activation and networking. From November 2012 to June 2013 (8 months) Waterbury, CTMedical Advisor @ PharmD Live Board Medical Advisor CTPhysician Consultant @ MCG Health Helping Providers and Payers both understand and achieve the maximum value of Evidenced Based Guidelines and Best Practice Operating Standards to implement and realize the Quadruple Aim: Improved Clinical Outcomes; Greater Patient Satisfaction; Greater Provider and Facility Satisfaction and Cost Containment. In a world where the complexity and rapidity of clinical innovation challenges the capacity of even the very best providers to guarantee that they are bringing their patients the most recent advances; where the fragmentation in healthcare delivery systems creates barriers to consistency and transparency; where integration of data, and an expanding scope of practice continually refine our perspectives; where shifts in the movement to greater value-based delivery, insights from AI and dynamic physiological data available through innovation in sensors create greater ever deeper understanding and the shift to a truly personalized medicine joins our awareness of the psychosocial drivers of health and illness which challenge us in turn to think in new ways about new approaches; practicing medicine at the highest level demands our capacity to embrace truly user-centric interfaces with expert systems to make that quadruple aim a reality; where these are the realities my role at MCG is to add my wisdom and experience to help our team drive truly measurable client-centered outcomes that maximize the value of our capabilities, expand our offerings to meet new demands and create business success for each client and improved outcomes for patients, taking clinical milestones and turning them into care plans and ultimately involving patients in the markers of clinical improvement that will signal that they are safe and sufficiently improved to make a good transition to their next level of care. From July 2018 to August 2019 (1 year 2 months) WoodbridgeExecutive Medical Officer and CMO @ Catalyst Rx (Catamaran 07/12) (Starting in July 2012 Catalyst was bought by SXC who changed the name of the combined companies to Catamaran). As Executive Medical Officer at Catamaran I was charged with incorporating the clinical visions of CatalystRx and SXC, infused with a focus on innovation to create an industry leading PBM value proposition in an industry in transformation. Part of the clinical leadership team for operations quality and policies, new product development, customer acquisition and retention and clinical PRAt Catalyst I was the CMO throughout my tenure and until the acquisition I led clinical strategy directing the team process in creating strategic innovation and positioning – Specialty Medication (oncology pathway programs); extension of PBM management to Jcode medications; Adherence and Consumerology ; Personalized Medicine; Social Marketing and culture-specific clinical programs; health reform consultation and system innovation and development (340B, PCMH, ACO strategies)Clinical Sales/ Account Renewals (All segment clinical consultant - Employer, Healthplan, State and Government) responsible as part of the preparation and finalist teams for over $300 million of new business with special emphasis on the retention of a $2.3 billion book of MCO business ; led the clinical due diligence and presented the clinical strategy for synergies on the Future Scripts, Walgreens, and Regents deals.Clinical Quality developed the Clinical Advisory Committee structure; oversaw quality initiatives and teams including URAC, NCQA; star-rating improvement teams; new policies and procedures; fraud waste and abuse strategies; clinical safety; disease management focus and development strategy for “Med Monitor” (clinical analytic tool)P&T Committee Supervision Commercial and MedicarePR and External Clinical Face of the Company Presentations at PBMI, URAC, PHQ conferences; customer webinars; board of the Wireless Innovation Council of Mobiquity (mhealth strategies) From April 2010 to November 2012 (2 years 8 months) Waterbury,CTCMO Strategy and Innovation @ Optum Health Behavioral Solutions CMO for Strategy and Innovation (2005–2010)Product Development/Integration Led incorporation of recent Innovations in Brain Health Strategy (including laying groundwork for direct to consumer with Prevention Magazine – codevelopment of i-applications with Brain Resource “My Calm Beat” using heart-rate variability training); International market development (India Market exploration with Apollo Hospitals; Major involvement in UK development with NHS); integration of social marketing and health psychology as key determinants in behavioral changeClinical Sales, GE. Hewlett Packard, CISCO, Sutter Health, University of California, Whirlpool, Aon, Geisinger Health Plan, Coventry, State of New Mexico ; in support of $50-100 million of new revenue annuallyHealth Solutions Consultant driving OHBS recognition, retention, satisfaction and market innovation (account value $200 million) GE, University of California, CISCO, Whirlpool, Railroad, Sutter Health, General Board of Pensions Methodist Church.Behavioral Liaison to Consultant Brokers Aon, Towers Perrin, Mercer, Hewitt, Watson Wyatt, Segal, Gallagher, WillisPR Presentations at the NBGH, NYBGH, DMEC (nationally and regionally);Employer meetings for Fortune 100 companies(GE National Medical Directors Meeting; Railroad, NALC; TV appearances selected markets; print media (WSJ; Employee Benefits; regular column DMEC); White Papers on health.; State and National Government Liaison on Select Issues From 2005 to 2010 (5 years) Independent Consultant @ David Whitehouse Assoc. Inc. Woodbridge, Connecticut, United StatesMedical Director @ AbleTo Inc. AbleTo is the premier platform for providing outcomes driven virtual behavioral health focused on aligning the unique needs of each member, be that the emotional and cognitive burden of managing chronic illness or employees distracted by the crises of daily living looking to develop the competencies necessary to take back full control of their emotional lives. My role includes furthering the excellent work in place that allows us to truly demonstrate value and go at risk for the same while we broaden the scope of the virtual interventions that can be offered. At the same time as we broaden the scope of services we look to further our knowledge around the needs for specific populations so that our targeted approach can provide comfort and hope to a greater swath of potential users. Acting as both a subject knowledge expert on healthcare delivery systems, human capital enhancement and member engagement in the digital era my position at AbleTo suppots sales, account management, product development and public relations. From August 2019 to September 2020 (1 year 2 months) Greater New York City AreaIndependent Consultant @ DAVID WHITEHOUSE ASSOCIATES LIMITED Working with clients including Senscio the leading delivery system in augmented home based monitoring and remote complex care management (hospital at home) driven by unique integration of physiological monitoring and situational context and patterns of living analytics powered by truly effective and powerful machine learning and artificial intelligence supported by human touch health navigators to create industry leading outcomes coupled with the highest patient satisfaction ratings. Also working as an advisor to Total Brain, as well as an advisor to CerraCap Ventures around health investments. From May 2017 to July 2018 (1 year 3 months) CMO Head of Digital Health Transformation @ UST Global In January of 2015 with the recent investments and shift of focus within UST to aligning services and capabilities to better meet the increasing need for digital innovation and transformation the role has expanded to responsibility for curating resources, stimulating innovation and overseeing deployment of industry leading solutions that combine the latest technology advances both within the health domain while leveraging cross domain insights from areas like telecommunication , banking and retail to generate best in class solutions for both traditional healthcare players (ACOs, PCMHs, IDSs, employers, third parties) as well as the increasing new markets such as retail clinic expansion and direct to consumer with the increasing importance of private and public exchanges and the new empowerment that consumers have with the digital metrics of wearables and self monitoring. World class capabilities from partnerships around "Design for Happiness" in conjunction with University of Delft, deep security capabilities out of Israel, and advanced analytic capabilities that incorporate the best of AI and traditional approaches to maximize the value from structured and unstructured data in the era of Big Data, coupled with core capabilities around BPO, device integration, interoperability, revenue cycle management, are all part of the portfolio that falls under this role, as does new customer acquisition and retention. From January 2015 to May 2017 (2 years 5 months) Chief Medical Officer @ UST Global The major focus of this role is to compliment the extensive reputation UST Global has in providing IT support, services and solutions to major healthcare clients such as Anthem/Wellpoint, Cleveland Clinic, MD Anderson, IBC, Highmark, and Costco among others in the US, and across the globe for clients such as Boots/Alliance, and the NHS in the UK, with guidance as to execution, prioritization and solution/situation fit. In all assignments the focus has been to add deep domain expertise so that, making use of the practical wisdom from extensive clinical and health systems experience and insights, UST can provide the highest value to assist present and future clients with an improved understanding of the significance, influence and possibilities of the ever expanding advances in technology capabilities and solutions available to consumers (including medical device development and deployment), as well as software solutions available for providers, and systems, including hospitals, ACOs, PCMHs, insurers, and PBMs from analytics, to claims processing, to operational support capabilities. Using deep perspectives on issues including the impact of big data on analytics and prediction; of ubiquitous sensors and the quantified self movement on advancing concepts of “expert patients” and in home capabilities; to the place of micronetworks and social networking on everything from gauging satisfaction to improving communication and resource allocation among providers, patients, their families and community care givers; to the impact of mobile applications on just in time information, enhanced communication and the use of avatars to put a trusted advisor in every home the role focuses on customer specific value maximization. As CMO my role is to insure the highest impact of interventions, speed their time to implementation and insure the maximum ROI clinically and financially while maintaining the highest level of individual consumer/patient/provider satisfaction. From June 2013 to May 2017 (4 years) Waterbury CT USA